Although one study shows positive PD-L1 expression in 13% (3/23) of mucosal malignant melanoma of head and neck [33], another study [34] did not find any clinical response by application of PD-1 inhibitors in a group of patients with advanced recurrent mucosal melanoma of head and neck. This evidence concerns the gene PDCD1 and melanoma.